| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |